CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease

Detalles Bibliográficos
Autores principales: Wang, Yinhan, Xu, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432308/
https://www.ncbi.nlm.nih.gov/pubmed/37600998
http://dx.doi.org/10.21037/hbsn-23-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432308/
https://www.ncbi.nlm.nih.gov/pubmed/37600998
http://dx.doi.org/10.21037/hbsn-23-247

Ejemplares similares